Board Meeting29 Jul 2026, 02:37 pm
Gennex Laboratories Board Meeting on Aug 14 to Approve Q1 FY27 Results
AI Summary
Gennex Laboratories Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the Unaudited Financial Statements (Standalone and Consolidated) for the quarter ended June 30, 2026. The meeting will also review the Limited Review Reports from the Statutory Auditor. The trading window, which was closed from July 1, 2026, will reopen 48 hours after the declaration of these financial results. The company will also discuss other business items.
Key Highlights
- Board meeting scheduled for August 14, 2026.
- To approve Unaudited Financial Statements for Q1 FY27.
- Limited Review Reports to be considered.
- Trading window to reopen 48 hours post results.
Price Impact
More from GENNEX